These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31400280)
1. Toxin A-Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype. Lin Q; Pollock NR; Banz A; Lantz A; Xu H; Gu L; Gerding DN; Garey KW; Gonzales-Luna AJ; Zhao M; Song L; Duffy DC; Kelly CP; Chen X Clin Infect Dis; 2020 Jun; 70(12):2628-2633. PubMed ID: 31400280 [TBL] [Abstract][Full Text] [Related]
2. Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection. Wang S; Heuler J; Wickramage I; Sun X Microbiol Spectr; 2022 Apr; 10(2):e0178821. PubMed ID: 35315695 [TBL] [Abstract][Full Text] [Related]
3. Predominance of Clostridioides difficile PCR ribotype 181 in northern Greece, 2016-2019. Kachrimanidou M; Metallidis S; Tsachouridou O; Harmanus C; Lola V; Protonotariou E; Skoura L; Kuijper E Anaerobe; 2022 Aug; 76():102601. PubMed ID: 35688364 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay. Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296 [TBL] [Abstract][Full Text] [Related]
5. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran. Doosti A; Mokhtari-Farsani A Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619 [TBL] [Abstract][Full Text] [Related]
6. Rare toxin A-negative and toxin B-positive strain of Clostridioides difficile from Japan lacking a complete tcdA gene. Takemori-Sakai Y; Satou K; Senda Y; Nakamura Y; Otani H; Maekawa A; Oe H; Oshima M; Yoneda-Nakagawa S; Miyagawa T; Sato K; Ogura H; Mori M; Wada T; Sakai Y; Yutani M; Matsumura T; Fujinaga Y; Gabata T; Wada T; Iwata Y J Infect Chemother; 2022 May; 28(5):651-656. PubMed ID: 35078721 [TBL] [Abstract][Full Text] [Related]
7. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure. Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481 [TBL] [Abstract][Full Text] [Related]
8. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection. Wang S; Zhu D; Sun X Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336 [TBL] [Abstract][Full Text] [Related]
9. Rapid Detection of Clostridium difficile Toxins in Stool by Raman Spectroscopy. Koya SK; Yurgelevic S; Brusatori M; Huang C; Diebel LN; Auner GW J Surg Res; 2019 Dec; 244():111-116. PubMed ID: 31279995 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results. Shah MD; Balada-Llasat JM; Coe K; Reed E; Sandlund J; Pancholi P J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32051264 [No Abstract] [Full Text] [Related]
12. Detoxification of toxin A and toxin B by copper ion-catalyzed oxidation in production of a toxoid-based vaccine against Clostridioides difficile. Aminzadeh A; Tiwari MK; Mamah Mustapha SS; Navarrete SJ; Henriksen AB; Møller IM; Krogfelt KA; Bjerrum MJ; Jørgensen R Free Radic Biol Med; 2020 Nov; 160():433-446. PubMed ID: 32860983 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010. Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742 [TBL] [Abstract][Full Text] [Related]
14. Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model. Qiu H; Cassan R; Johnstone D; Han X; Joyee AG; McQuoid M; Masi A; Merluza J; Hrehorak B; Reid R; Kennedy K; Tighe B; Rak C; Leonhardt M; Dupas B; Saward L; Berry JD; Nykiforuk CL PLoS One; 2016; 11(6):e0157970. PubMed ID: 27336843 [TBL] [Abstract][Full Text] [Related]
16. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495 [TBL] [Abstract][Full Text] [Related]
17. Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection. Shin BM; Kuak EY; Lee EJ; Songer JG J Clin Microbiol; 2009 Sep; 47(9):2952-6. PubMed ID: 19625481 [TBL] [Abstract][Full Text] [Related]
18. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model. Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928 [TBL] [Abstract][Full Text] [Related]
20. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital]. Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]